Screening of Natural Compounds as Inhibitor of M<sup>pro</sup> SARS-CoV-2 Protein; AMolecular Dynamics Approach
Considering the limitations of currently available vaccines, our study may provide new insight into potential drugs that may prevent SARS-CoV-2 infection in humans.
Authors
- Anum Javaid
- Naeem Mahmood Ashraf (ORCID: https://orcid.org/0000-0003-3614-0702)
- Arslan Hamid (ORCID: https://orcid.org/0000-0002-2861-013X)
- Mahjabeen Saleem (ORCID: https://orcid.org/0000-0001-8944-8714)
- Nousheen Bibi (ORCID: https://orcid.org/0000-0001-8399-0932)
- Ali Almajwal (ORCID: https://orcid.org/0000-0002-9798-7117)
- Sana Batool (ORCID: https://orcid.org/0000-0002-9300-9172)
- Hina Batool
- Malik Siddique Mahmood (ORCID: https://orcid.org/0000-0002-8007-6843)
- Suhail Razak (ORCID: https://orcid.org/0000-0003-2167-8630)
- Tayyaba Afsar (ORCID: https://orcid.org/0000-0003-3181-5731)
Institutions
- Shaheed Benazir Bhutto Women University Peshawar (PK)
- University of Bonn (DE)
- University of the Punjab (PK)
- King Saud University (SA)
- University of Management and Technology (PK)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2024-11-20
- DOI
- https://doi.org/10.2174/0113816128315762240828052002
- Primary Topic
- Diverse Scientific Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00